Related Experiment Video

Updated: Aug 21, 2026

Rapid Screening of HIV Reverse Transcriptase and Integrase Inhibitors
05:46

Rapid Screening of HIV Reverse Transcriptase and Integrase Inhibitors

Published on: April 9, 2014

HIV-related cardiovascular disease and drug interactions

Kinjal A Nanavati1, Stacy D Fisher, Tracie L Miller

  • 1Sinai Hospital of Baltimore, Baltimore, Maryland, USA.

American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions
|September 29, 2004
PubMed

Insights

HIV infection significantly impacts heart health, leading to various cardiovascular issues like heart failure and arrhythmias. Early detection and treatment of these conditions in HIV patients are crucial for reducing mortality and improving outcomes.

Area of Science:

  • Cardiology
  • Infectious Diseases
  • Public Health

Background:

  • Human Immunodeficiency Virus (HIV) infection is a global health concern with significant cardiovascular implications.
  • HIV-associated cardiovascular manifestations are often subtle, leading to misdiagnosis or delayed recognition.
  • Cardiovascular complications contribute substantially to morbidity and mortality in HIV-infected individuals.

Purpose of the Study:

  • To highlight the spectrum of cardiovascular involvement in HIV infection.
  • To emphasize the importance of routine cardiovascular screening in HIV patients.
  • To discuss the impact of antiretroviral therapy and its cardiovascular side effects.

Main Methods:

  • Review of existing literature on HIV and cardiovascular disease.
  • Analysis of common and emergent cardiovascular complications in HIV-infected populations.
  • Discussion of therapeutic strategies and their cardiovascular effects.

Main Results:

  • Left ventricular dysfunction, a key mortality predictor, affects up to 10% of HIV patients, potentially leading to cardiomyopathy and heart failure.
  • Other significant cardiovascular issues include pulmonary arterial hypertension, vasculitis, premature atherosclerosis, and arrhythmias.
  • Cardiovascular emergencies in HIV patients encompass heart failure, arrhythmias, endocarditis, and tamponade.
  • Highly active antiretroviral therapy (HAART) can lead to metabolic changes like lipodystrophy and hyperlipidemia, while also posing risks such as drug-induced arrhythmias and accelerated atherosclerosis.

Conclusions:

  • Cardiovascular complications are critical determinants of health outcomes in HIV-infected patients.
  • Proactive screening and management of cardiac issues in HIV are essential for reducing mortality.
  • Understanding the interplay between HIV, its treatments, and cardiovascular health is vital for comprehensive patient care.

More Related Videos

Oral Combinational Antiretroviral Treatment in HIV-1 Infected Humanized Mice06:07

Oral Combinational Antiretroviral Treatment in HIV-1 Infected Humanized Mice

Published on: October 6, 2022

Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors10:29

Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors

Published on: May 9, 2025

Related Concept Videos

Pharmacokinetics: Drug–Food and Drug–Viral Interactions01:26

Pharmacokinetics: Drug–Food and Drug–Viral Interactions

A drug interaction occurs when the concurrent use of another drug, food, or an external substance alters the pharmacological activity of a drug. This interaction can modify the action of the original drug, affecting its effectiveness and safety.Drug–food interactions are significant as they impact drug absorption, metabolism, and excretion. For example, grapefruit juice is a well-known disruptor of drug metabolism. It inhibits the cytochrome P450 3A4 enzyme, crucial for the metabolism of many...
Pharmacokinetics: Drug–Drug Interactions01:25

Pharmacokinetics: Drug–Drug Interactions

Drug interactions occur when the pharmacological effect of one drug is altered by another substance, either enhancing or diminishing its activity. The drug whose activity is altered is known as the object drug, and the substance causing the alteration is called the agent drug or the precipitant. The net effects of these interactions are mostly undesirable, leading to decreased effectiveness or increased adverse effects. In rare cases, interactions can be beneficial, such as the enhanced...
Drug toxicity: Drug–Drug Interaction01:30

Drug toxicity: Drug–Drug Interaction

Drug–drug interactions can precipitate toxicity through multiple mechanisms. Absorption interactions alter how drugs enter the body, exemplified when ranitidine increases the absorption of basic drugs, while cholestyramine decreases the levels of propranolol. Protein binding interactions occur when drugs share the same binding sites on plasma proteins. Drugs like aspirin and warfarin, when bound in excess, can lead to increased free drug concentrations, enhancing the potential for...
Factors Affecting Protein-Drug Binding: Drug Interactions01:23

Factors Affecting Protein-Drug Binding: Drug Interactions

Drug interactions are a critical aspect of pharmacology and can occur when two or more drugs compete for the same binding site. This competition can result in one drug displacing another, altering the effect of the displaced drug. Drug interactions are complex processes that rely heavily on how much of the displacer drug is present and how strongly it can bind to the same sites as the displaced drug.
Displacement interactions can have varying outcomes, ranging from toxicity to virtually...
Cardiovascular Drugs: Classification based on Therapeutic Indications01:18

Cardiovascular Drugs: Classification based on Therapeutic Indications

Cardiovascular diseases, encompassing a range of conditions, can significantly affect the heart's operations and the overall circulatory system. These conditions impair the heart's ability to pump blood, leading to a deficit in oxygen supply to crucial organs. Anomalies in the heart's electrical system, known as arrhythmias, can cause heartbeats to accelerate or slow down. Usually, heart rates increase during physical activity and decrease while resting or sleeping. However, frequent irregular...
Retrovirus Life Cycles01:10

Retrovirus Life Cycles

Retroviruses have a single-stranded RNA genome that undergoes a special form of replication. Once the retrovirus has entered the host cell, an enzyme called reverse transcriptase synthesizes double-stranded DNA from the retroviral RNA genome. This DNA copy of the genome is then integrated into the host’s genome inside the nucleus via an enzyme called integrase. Consequently, the retroviral genome is transcribed into RNA whenever the host’s genome is transcribed, allowing the retrovirus to...